SMSPHARMABSESMS Pharmaceuticals LtdHighNegative
Announced Fri, 22 Aug · 15:53 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hima Bindu Potluri

Ownership Changes View source PDF

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hima Bindu Potluri, part of the promoter group of SMS Pharmaceuticals, released a Non-Disposal Undertaking (NDU) on 30,00,000 equity shares (3.38% of capital) on 19 August 2025. On 20 August 2025, she created a pledge on those same 30 lakh shares in favour of Vistra ITCL (India) Ltd (Debenture Trustee) on behalf of Avendus PE Investment Advisors (Debenture Holder). The pledge is security for debentures issued by Potluri Laboratories Pvt Ltd, another promoter entity. Her total holding is 1,50,08,840 shares (16.93% of capital), with encumbrance of 1,36,20,000 shares (15.36%). The NDU was effectively replaced by a pledge — the number of encumbered shares is unchanged.

Likely market impact

This is a restructuring of encumbrance, not a new pledging event — the same shares remain encumbered under a pledge instead of an NDU, so ownership and total encumbrance are unchanged. However, with over 15% of promoter holdings pledged as security for promoter-group debentures, shareholders should monitor any stress on those debentures as it could indirectly affect pledged shares.